Renal Cell Carcinoma

Renal cell carcinoma (RCC) represents 2-3% of all cancers. Learn more about this disease, its diagnosis and treatments.

2–3 %

of all cancers

Many

renal masses remain asymptomatic

Surgery

is the first treatment option

Neuroendocrine tumors

Neuroendocrine tumors (NETs) are most commonly found in the gastrointestinal tract. Sometimes asymptomatic, they can secrete abnormally high amounts of hormones that affect body functions and can cause digestive system problems, weight loss and flushing (redness of the skin and hot flushes). Learn more about this rare endocrine disease, its diagnosis and the different treatment options available.

Prostate cancer

Prostate cancer is the most frequently occurring cancer in men over the age of 50 and is the second most common cause of death from cancer after lung cancer. Learn more about the condition, its diagnosis and the different treatment options available.
Sources :

1 Chow WH, Dong LM, Devesa SS. . Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7: 245–257
2 European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary (2001), Lyon, 2001.
3 Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004;93(2):88-96 http://www.ncbi.nlm.nih.gov/pubmed/15285559
4 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013 Apr;49(6):1374-403. http://www.ncbi.nlm.nih.gov/pubmed/23485231
5 Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008 Apr;101(8):949-58 http://www.ncbi.nlm.nih.gov/pubmed/18241251
6 Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
7 Guidelines on Renal Cell Carcinoma, European Association of Urology, 2014– Uroweb.org
8 American Cancer Society. https://www.cancer.org/cancer/kidney-cancer
9 European Association of Urology. Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor–Targeted Therapy
Last update 13/04/2017